Obvio Laboratories: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Obvio Laboratories
Largest movements
- Stocks and contracts +€36,787
new in 2025: €36,787
- Receivables within one year +€8,134
up €8,134 (+3,297%), from €247 to €8,381
of which Trade receivables: +€4,714
- Cash +€4,306
up €4,306 (+30.1%), from €14,281 to €18,587
mainly Other debts (+€100,248) and Depreciation (+€24,252)
- Intangible fixed assets -€3,795
down €3,795 (-4.8%), from €79,648 to €75,853
- Other debts +€100,248
up €100,248 (+299%), from €33,557 to €133,806
- Profit (loss) carried forward -€33,304
down €33,304 (-112%), from -€29,825 to -€63,129
- Trade debts -€12,929
down €12,929 (-73.6%), from €17,565 to €4,635
- Investment grants -€7,413
down €7,413 (-32.1%), from €23,102 to €15,689
- Depreciation +€11,410
up €11,410 (+88.8%), from €12,843 to €24,252
- Gross operating margin -€6,860
down €6,860 (-75.9%), from -€9,037 to -€15,896
- Financial income +€1,215
up €1,215 (+19.5%), from €6,221 to €7,436
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €94,399 | €141,001 | +€46,603 | +49.4% |
| Fixed assets | 21/28 | €79,828 | €76,848 | -€2,980 | -3.7% |
| Intangible fixed assets | 21 | €79,648 | €75,853 | -€3,795 | -4.8% |
| Tangible fixed assets | 22/27 | - | €815 | +€815 | |
| Furniture and vehicles | 24 | - | €815 | +€815 | |
| Financial fixed assets | 28 | €180 | €180 | = | 0.0% |
| Current assets | 29/58 | €14,571 | €64,154 | +€49,583 | +340% |
| Stocks and contracts in progress | 3 | - | €36,787 | +€36,787 | |
| Stocks | 30/36 | - | €36,787 | +€36,787 | |
| Amounts receivable within one year | 40/41 | €247 | €8,381 | +€8,134 | +3,297% |
| Trade receivables | 40 | €80 | €4,794 | +€4,714 | +5,899% |
| Other amounts receivable | 41 | €167 | €3,586 | +€3,419 | +2,050% |
| Cash at bank and in hand | 54/58 | €14,281 | €18,587 | +€4,306 | +30.1% |
| Deferred charges and accrued income | 490/1 | €43 | €399 | +€356 | +829% |
| Total equity and liabilities | 10/49 | €94,399 | €141,001 | +€46,603 | +49.4% |
| Equity | 10/15 | €43,277 | €2,560 | -€40,716 | -94.1% |
| Contributions | 10/11 | €50,000 | €50,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€29,825 | -€63,129 | -€33,304 | -112% |
| Investment grants | 15 | €23,102 | €15,689 | -€7,413 | -32.1% |
| Amounts payable | 17/49 | €51,122 | €138,441 | +€87,319 | +171% |
| Amounts payable within one year | 42/48 | €51,122 | €138,441 | +€87,319 | +171% |
| Trade debts | 44 | €17,565 | €4,635 | -€12,929 | -73.6% |
| Suppliers | 440/4 | €17,565 | €4,635 | -€12,929 | -73.6% |
| Other amounts payable | 47/48 | €33,557 | €133,806 | +€100,248 | +299% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €12,843 | €24,252 | +€11,410 | +88.8% |
| Other operating charges | 640/8 | €454 | €457 | +€3 | +0.6% |
| Gross operating margin | 9900 | -€9,037 | -€15,896 | -€6,860 | -75.9% |
| Operating profit (loss) | 9901 | -€22,334 | -€40,606 | -€18,273 | -81.8% |
| Financial income | 75/76B | €6,221 | €7,436 | +€1,215 | +19.5% |
| Recurring financial income | 75 | €6,221 | €7,436 | +€1,215 | +19.5% |
| Financial charges | 65/66B | €120 | €134 | +€13 | +11.0% |
| Recurring financial charges | 65 | €120 | €134 | +€13 | +11.0% |
| Profit (loss) for the period before taxes | 9903 | -€16,233 | -€33,304 | -€17,071 | -105% |
| Profit (loss) for the period | 9904 | -€16,233 | -€33,304 | -€17,071 | -105% |
| Profit (loss) for the period to be appropriated | 9905 | -€16,233 | -€33,304 | -€17,071 | -105% |
Source: filed annual accounts (NBB), financial years ended 31 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.